Relenopride

DB12798InvestigationalSmall molecule

Relenopride has been used in trials studying the treatment of Chronic Idiopathic Constipation.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 4
Curator reviewed
Formula / weight: C₂₄H₃₀ClFN₄O₄ · 492.98 g/mol (avg)
Code names: YKP-10811

Resolves to

Compound

Structure

InChIKeyKGMMSPVVHZGPHL-NRFANRHFSA-NSMILESCOC1=CC(N)=C(Cl)C=C1C(=O)NCC1CCN(CC[C@H](OC(N)=O)C2=CC=C(F)C=C2)CC1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Relenopride, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.